Arq. Bras. Oftalmol. 2024; 87 (3): 10.5935/0004-2749.2021-0514
Total: 2689
Bruna Vieira Ventura1,2; Mariana Zaira Ribeiro1; Nayara Rayanne Bezerra Caldas1; Larissa Ventura1,2; Polyana Marinho1,2; Rodrigo Pessoa Cavalcanti Lira3; Camilla Silva da Rocha1; Marcelo Carvalho Ventura1,2
DOI: 10.5935/0004-2749.2021-0514
1. Fundação Altino Ventura, Recife, PE, Brazil
2. Hospital de Olhos de Pernambuco, Recife, PE, Brazil
3. Universidade Federal de Pernambuco, Recife, PE, Brazil
Bruna V. Ventura
E-mail: [email protected]
Funding: This study received no specific financial support.
Disclosure of potential conflicts of interest: Ventura BV: consultant to Alcon Laboratories, Inc., Johnson & Jonhson Vision, Inc. and Cristalia Pharmaceutical; The other authors do not have any potential conflicts of interest to disclose.
Approved by the following research ethics committee: Fundação Altino Ventura (CAAE: 58389416.1.0000.5532).
How to cite this article:
ABO is licensed under a Creative Commons Attribution-NonComercial 4.0 Internacional.
